Common Contracts
2 similar null contracts by Arqule Inc, Genvec Inc
Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENTGenvec Inc • September 21st, 2005 • Pharmaceutical preparations • New York
GenVec, Inc., a Delaware corporation (the “Company”), pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Purchase Agreements in the form of Exhibit A attached hereto (the “Purchase Agreements”) entered into with the purchasers identified therein (each a “Purchaser” and, collectively, the “Purchasers”), proposes to sell to the Purchasers an aggregate of 7,650,000 shares of Common Stock, par value $0.001 per share, together with associated stock purchase rights (the “Common Stock”) of the Company. The aggregate of 7,650,000 shares of Common Stock so proposed to be sold by the Company is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with SG Cowen & Co., LLC (“SG Cowen” or the “Placement Agent”) as follows (certain terms herein are defined in Section 13 hereof):
ARQULE, INC. 5,788,095 Shares of Common Stock, $.01 par value per share PLACEMENT AGENT AGREEMENTArqule Inc • January 25th, 2005 • Pharmaceutical preparations • New York
ArQule, Inc., a Delaware corporation (the “Company”), proposes to sell to certain purchasers (each a “Purchaser” and, collectively, the “Purchasers”), pursuant to the terms of this Placement Agent Agreement (this “Agreement”), an aggregate of up to 5,788,095 shares of Common Stock, par value $.01 per share (the “Common Stock”), of the Company. The aggregate of 5,788,095 shares so proposed to be sold is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with J.P. Morgan Securities Inc. (“JPMorgan”) as follows (certain terms used herein are defined in Section 13 hereof):
